| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
PKN3 |
PKN3, PKNBETA: Serine/threonine-protein kinase N3 |
20.550 |
Evidence |
|
| HCK |
IPI00029769 |
SH3KBP1 |
SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 |
20.550 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
20.550 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
20.550 |
Evidence |
|
| GSN |
GSN: Gelsolin precursor |
ACTR3 |
ACTR3, ARP3: Actin-related protein 3 |
20.550 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
SNX3 |
IPI00029740 |
20.550 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
NEK6 |
NEK6: Serine/threonine-protein kinase Nek6 |
20.550 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
CD2AP |
CD2AP: CD2-associated protein |
20.550 |
Evidence |
O
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
DOK1 |
DOK1: Docking protein 1 |
20.550 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
CNKSR2 |
CNKSR2, CNK2, KIAA0902, KSR2: Connector enhancer of kinase suppressor of ras 2 |
20.550 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
DAB2 |
DAB2, DOC2: Disabled homolog 2 |
20.550 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
20.550 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
20.550 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
CSNK1E |
CSNK1E: Casein kinase I isoform epsilon |
20.550 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PIK3CG |
PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i |
20.550 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
20.550 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
20.550 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
TRPM7 |
TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me |
20.550 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
PTPRF |
PTPRF, LAR: Receptor-type tyrosine-protein phosphatase F precursor |
20.550 |
Evidence |
|
| PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
20.550 |
Evidence |
|
| PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
20.550 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PRKACA |
PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit |
20.550 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
CDC25C |
CDC25C: M-phase inducer phosphatase 3 |
20.550 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
20.550 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
MKNK1 |
MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 |
20.550 |
Evidence |
|